Latest Breaking News On - ஜான்சன் மருந்து நிறுவனம் - Page 1 : comparemela.com

Confirm – Expansion of management team with proven leader in cardiovascular disease supports advancement of CLEAR Outcomes trial and ESPERION therapeutic pipeline – ANN ARBOR, Mich., June 28, 2021 (GLOBE NEWSWIRE) ESPERION ( ESPR), today announced the appointment of JoAnne Micale Foody, MD, FACC, FAHA as Chief Medical Officer, effective immediately. She will serve as a member of the executive team and report to Sheldon Koenig, President and Chief Executive Officer. Dr. Foody brings more than 20 years of experience in academic and preventive cardiology to ESPERION. “Dr. Foody is a global expert with extensive clinical and medical experience in preventive cardiology, global medical development and medical affairs, which adds greatly to the depth of our management team,” said Sheldon Koenig, President and Chief Executive Officer of ESPERION. “JoAnne joins ESPERION at a critical period for the Company as we continue to drive towards the completion of our landmark CLEAR Out

United statesJoanne micale foodySheldon koenigJanssen pharmaceutical companyAmerican heart associationBen churchLipid management companyCardiovascular medical affairs for janssenMerck research labsUniversity of chicagoDevelopment team leader for janssen xareltoHead of data sciences for cardiovascularAmerican college of cardiologyPrinceton universityCleveland clinic foundation inExchange commission